Byung-Tae Noh

Vorstandsvorsitzender bei DAE HWA PHARMACEUTICAL CO., LTD.

Vermögen: 431 023 $ am 31.05.2024

62 Jahre

Health Technology

Consumer Services

Profil

Byung-Tae Noh is currently the Chairman & Co-Chief Executive Officer at DAE HWA PHARM Co., Ltd.
He previously worked as a Director at RedoxBio Co., Ltd.
Mr. Noh completed his undergraduate degree at Daegu University.

Bekannte Unternehmensbeteiligungen

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
RedoxBio Co., Ltd. RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology RedoxBio Co., Ltd. engages in the manufacture and sale of materials for pharmaceutical products. It operates through Hyaluronic Acid and Chemical business divisions. Its products include hyaluronic filler, methylol cephalexin lysinate, sodium hyaluronate, and others. The company was founded on August 26, 2010 and is headquartered in Hwaseong-si, South Korea. 0,41%	31.03.2023	100 000 ( 0,41% )	239 971 $	31.12.2020
DAE HWA PHARM CO., LTD. 0,15%	27.12.2023	27 583 ( 0,15% )	191 052 $	31.05.2024

Aktive Positionen von Byung-Tae Noh

Unternehmen	Position	Beginn
DAE HWA PHARMACEUTICAL CO., LTD.	Vorstandsvorsitzender	20.03.2015

Alle aktiven Positionen von Byung-Tae Noh

Ehemalige bekannte Positionen von Byung-Tae Noh

Unternehmen	Position	Ende
RedoxBio Co., Ltd. RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology RedoxBio Co., Ltd. engages in the manufacture and sale of materials for pharmaceutical products. It operates through Hyaluronic Acid and Chemical business divisions. Its products include hyaluronic filler, methylol cephalexin lysinate, sodium hyaluronate, and others. The company was founded on August 26, 2010 and is headquartered in Hwaseong-si, South Korea.	Direktor/Vorstandsmitglied	-